Examinando por Materia "Seguro de Salud"

Mostrando 1 - 3 de 3

Acceso abierto
Desigualdad en la Mortalidad Neonatal del Perú asociada a la pobreza, educación y afiliación a seguro de salud. Perú, 2011 – 2019
(Universidad Privada Norbert Wiener, 2022-01-27) Avila Vargas Machuca, Jeannette Giselle; Benites Castillo, Santiago Moises
The objective was to evaluate the magnitude and trend of inequality in the Neonatal Mortality Rate (NMR) generated by poverty, education and affiliation to health insurance, between departments of Peru, years 2011-2019. We did an ecological study based on the analysis of social inequalities in health. We calculate absolute (GA), relative (GR) inequality gap metrics and social gradient metrics: Slope Inequality Index (SII) and Health Concentration Index (CI). We use population survey data. We found higher NMR in departments with greater poverty, less education and greater affiliation to health insurance. About the NMR generated by poverty, GA went from 8.13 to 2.24 between 2011-2019 and the GR went from 2.08 to 1.31. The GA of the NMR according to education went from 6.08 to 2.31 and the GR from 1.83 to 1.28. The SII for 2019 was -4.03 for poverty, -3.74 for education and 2.90 for affiliation to health insurance. The CI registered values close to zero and with a tendency to decrease; 0.07 for poverty, 0.06 for education and 0, 05 for health insurance affiliation. We conclude that social inequality in neonatal mortality registered among the departments of Peru decreased between 2011 and 2019, reaching values of low magnitude. The Ministry of Health must continue to reduce neonatal mortality by promoting interventions with a greater population focus.
Acceso abierto
Prescripción de medicamentos del Seguro Integral de Salud (SIS) en niños menores de 11 años en un establecimiento de salud urbano marginal, enero–junio 2013
(Universidad Privada Norbert Wiener, 2015) Cabrera Palomino, Lucy; Ramos Matos, Lucinda Zelmira; Crispín Pérez, Víctor
According to the World Health Organization (WHO), the rational use of medicines implies that patients receive drugs suitable for their clinical needs, in appropriate doses, and for an adequate duration of time. In clinical practice, most medical consultations end with a prescription. The Comprehensive Health Insurance (SIS) provides health services to populations living in extreme poverty, although with certain limitations. The main objective of this study was to evaluate medicine prescriptions under the SIS program in children under 11 years of age at the San Fernando Health Center, San Juan de Lurigancho, a primary care facility, between January and June 2013. The study population consisted of 1,214 prescriptions issued to 806 children under 11 years of age. This was a descriptive, retrospective, and observational study, based on the analysis of medical prescriptions, which were organized into databases using Microsoft Office Excel 2010. The findings showed that the largest number of prescriptions were issued for male children (418; 51.9%). The most represented age group was children aged 0–2 years (37.7%), followed by those aged 3–5 years (32.3%). The most common diagnosis was acute pharyngitis (40.3%). The therapeutic groups with the highest prescription rates were anti-inflammatory drugs (39.5%), antibiotics (25.2%), and antihistamines (20.3%). Among antibiotics, amoxicillin 250 mg/5 ml suspension (60 ml) was the most frequently prescribed (50.2%). Oral administration was the predominant route (94.1%). In conclusion, medicine prescriptions under the SIS program for children under 11 years of age were mainly associated with acute pharyngitis, with anti-inflammatory drugs, antibiotics, and antihistamines being the most frequently prescribed, especially oral formulations.
Acceso abierto
Relación entre la disponibilidad de medicamentos esenciales y el gasto de bolsillo en el Perú, 2021-2024
(Universidad Privada Norbert Wiener, 2026-05-13) Chinguel Martinez, Desly Maribel; Espinoza Olivos, Miluska; Cano Pérez, Carlos Alfredo
La presente investigación tuvo como objetivo analizar la relación entre la disponibilidad de medicamentos esenciales y el gasto de bolsillo en medicamentos de la población peruana durante 2021 y 2024. Se desarrolló un estudio observacional, ecológico, analítico y longitudinal de series temporales cortas, utilizando información agregada del Sistema Integrado de Suministro de Medicamentos (SISMED) y la Encuesta Nacional de Hogares (ENAHO), con análisis trimestral mediante estadística descriptiva y modelos de regresión lineal con errores estándar de NeweyWest (lag 2). Los resultados evidenciaron que la disponibilidad de medicamentos esenciales con stock mayor a dos meses aumentó de 67.35% en 2021 a 84.41% en 2024, mientras el gasto de bolsillo trimestral se redujo de S/ 36.19 a S/ 26.61 (−26%). En el modelo simple, un incremento de un punto porcentual en la disponibilidad se asoció con un aumento de S/ 0.30 en el gasto trimestral, y la tendencia temporal mostró una reducción de S/ 1.23 por trimestre. Al incorporar el aseguramiento, el efecto de la disponibilidad se redujo a valores cercanos a cero, mientras que cada punto porcentual adicional de cobertura se asoció con una disminución de S/ 2.04 en el gasto. Se concluyó que la variación del gasto de bolsillo en medicamentos entre 2021 y 2024 se explicó principalmente por la evolución temporal y el incremento del aseguramiento en salud, más que por un efecto independiente de la disponibilidad de medicamentos esenciales.